- Home
- MED vs INMB Comparison
MED vs INMB Comparison
Compare MED & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- INMB
- Stock Information
- Founded
- MED 1980
- INMB 2015
- Country
- MED United States
- INMB United States
- Employees
- MED N/A
- INMB N/A
- Industry
- MED Packaged Foods
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- MED Consumer Staples
- INMB Health Care
- Exchange
- MED Nasdaq
- INMB Nasdaq
- Market Cap
- MED 187.3M
- INMB 203.5M
- IPO Year
- MED N/A
- INMB 2019
- Fundamental
- Price
- MED $14.73
- INMB $8.59
- Analyst Decision
- MED Hold
- INMB Strong Buy
- Analyst Count
- MED 1
- INMB 2
- Target Price
- MED $16.50
- INMB $21.50
- AVG Volume (30 Days)
- MED 230.8K
- INMB 462.2K
- Earning Date
- MED 02-18-2025
- INMB 03-27-2025
- Dividend Yield
- MED N/A
- INMB N/A
- EPS Growth
- MED N/A
- INMB N/A
- EPS
- MED 0.19
- INMB N/A
- Revenue
- MED $602,463,000.00
- INMB $42,000.00
- Revenue This Year
- MED N/A
- INMB N/A
- Revenue Next Year
- MED N/A
- INMB N/A
- P/E Ratio
- MED $77.53
- INMB N/A
- Revenue Growth
- MED N/A
- INMB N/A
- 52 Week Low
- MED $13.57
- INMB $4.32
- 52 Week High
- MED $42.68
- INMB $13.52
- Technical
- Relative Strength Index (RSI)
- MED 39.93
- INMB 51.55
- Support Level
- MED $13.57
- INMB $8.90
- Resistance Level
- MED $16.66
- INMB $9.58
- Average True Range (ATR)
- MED 0.74
- INMB 0.93
- MACD
- MED -0.02
- INMB -0.20
- Stochastic Oscillator
- MED 37.54
- INMB 16.23
About MED MEDIFAST INC
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.